UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

 

Filed by the Registrant ☒

 

Filed by a party other than the Registrant ☐

 

Check the appropriate box:

 

☐   Preliminary Proxy Statement

 

☐   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

☐   Definitive Proxy Statement

 

☒   Definitive Additional Materials

 

☐   Soliciting Material under §240.14a-12

 

MONOPAR THERAPEUTICS INC.

(Name of Registrant as Specified in Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

☒   No fee required.

 

☐   Fee paid previously with preliminary materials.

 

☐   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a–6(i)(1) and 0–11.